Explore this issue of The New England Journal of Medicine (Vol. 393 No. 8).

A 28-year-old woman presented to the emergency department because of abdominal pain, nausea, vomiting, and dizziness. The body-mass index was 18, and the anion gap was elevated. A diagnosis was made.

A study noted a sharp increase in leucovorin prescriptions dispensed to children (≤17 years of age) after a plan was ...

Explore the current issue of The New England Journal of Medicine (Vol. 395 No. 7).

In this issue of the Journal, Fong et al. report the results of a phase 1 trial of a new cancer therapy involving 60 patients (ClinicalTrials.gov number, NCT00516373). 1 Readers may be surprised by ...

A 55-year-old man with a smoking history of 10 pack-years presented with 2 years of an enlarging, painless lump below his right ear. A previously unnoticed smaller mass in the left parotid gland ...

A 31-year-old man was evaluated for an abnormal ECG. Echocardiography revealed marked ventricular hypertrophy. Subsequent ...

As the health of his brother and running buddy rapidly declines and he faces his own health scares, a physician feels compelled — and grateful — to keep moving forward.

Personalized therapies hold tremendous promise but challenge traditional models of drug and biologic development. The FDA outlines a path to market entry for products where a randomized trial is no ...

A patient with high-level HLA sensitization received T-cell engager–mediated HLA antibody depletion with teclistamab, a bispecific B-cell maturation antigen–directed CD3 T-cell engager, which enabled ...

In the article on their recent cluster-randomized trial, Lim et al. (March 26 issue)1 reported that the risk of dengue was reduced through the release of wolbachia-infected male ...

To the Editor: In the REDEFINE 1 trial, Garvey and colleagues (Aug. 14 issue) 1 report the efficacy of combination therapy with cagrilintide and semaglutide (known as CagriSema) in patients with ...